Jefferies Maintains Hold on Volcano Corp. (VOLC)

Jefferies is out with its report on Volcano VOLC maintaining Hold. In a note to clients, Jefferies writes, "Despite the ample room for continued adoption of Volcano's core technologies, we remain cautious on VOLC shares on the basis of pending litigation with St. Jude Medical (STJ, $42.05, Buy) surrounding the next-generation vascular imaging technology, OCT. Volcano's various technologies have considerable room for growth; however, uncertainty around the company's position in the next generation imaging technology called OCT keeps us at Hold." Jefferies maintains a $25 PT on VOLC. VOLC closed yesterday at $27.84